The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Major adverse cardiovascular events (MACE) in cancer patients treated with tirzepatide compared to GLP-1 receptor agonists: A target trial emulation using real-world data.
 
Omer Ashruf
No Relationships to Disclose
 
Ali Mushtaq
No Relationships to Disclose
 
Cindy (Hsin-Ti) Lin
No Relationships to Disclose
 
Maximilian Volk
No Relationships to Disclose
 
Zara Orozco
No Relationships to Disclose
 
Jasmin Hundal
No Relationships to Disclose
 
Ahmad Safdar
No Relationships to Disclose
 
Cole Thompson
No Relationships to Disclose
 
Sarim Karimi
No Relationships to Disclose
 
Akriti Jain
Honoraria - Curio Science; MJH Life Sciences; Targeted Oncology
Consulting or Advisory Role - SOBI; Takeda
Speakers' Bureau - Rigel
Research Funding - Novartis
 
Jasmine Sukumar
Honoraria - Sanofi (I)
 
Rohit Moudgil
No Relationships to Disclose
 
Sudipto Mukherjee
Honoraria - Aplastic Anemia and MDS International Foundation; McGraw-Hill Education
Consulting or Advisory Role - Abbvie/Genentech; Blueprint Medicines; Bristol-Myers Squibb; EUSA Pharma; Novartis; OncLive; Paradigm
Speakers' Bureau - EUSA Pharma
Research Funding - Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - EUSA Pharma
 
Gary Schwartz
Stock and Other Ownership Interests - Bionaut Labs; GenCirq
Consulting or Advisory Role - Bionaut Labs; Concarlo; Ipsen; OnCusp Therapeutics; PTC Therapeutics; Ratiopharm
Patents, Royalties, Other Intellectual Property - Companion diagnostics for CD4 inhibitors (Inst); patent granted to develop a new technology called PNAs for cancer therapy
 
David Kaelber
No Relationships to Disclose
 
Wen Ma
No Relationships to Disclose
 
Alex Adjei
Consulting or Advisory Role - EMD Serono; Iambic; Mirati Therapeutics; Swiss Rockets
Research Funding - BioNtech (Inst); BridgeBio Pharma (Inst); Kronos Bio (Inst); Pfizer (Inst)
(OPTIONAL) Uncompensated Relationships - Merck KGaA; Swiss Rockets; Zai Lab
 
Moaath Mustafa Ali
Consulting or Advisory Role - Daiichi Sankyo/Lilly; Daiichi Sankyo/Lilly
 
Abhay Singh
Research Funding - NANETS Clinical Investigator Scholarship (NCIS); Robert A. Winn Career Development Award (Winn CDA)